NRG1271 is an orally active mitochondrial permeability transition pore ( mPTP ) inhibitor with blood-brain barrier penetration. NRG1271 can be used for the study of Neurological Disease .
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Mitochondrial Metabolism
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。